Mps Loria Financial Planners, LLC Abb Vie Inc. Transaction History

Mps Loria Financial Planners, LLC

$332 Million
Q3 2024

A detailed history of Mps Loria Financial Planners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mps Loria Financial Planners, LLC holds 16,200 shares of ABBV stock, worth $2.92 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares

16,200

Previous 17,294 6.33%

Holding current value

$2.92 Million

Previous $2.97 Million 7.86%

% of portfolio

0.96%

Previous 0.96%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$163.84 - $199.33 $179,240 - $218,067	-1,094 Reduced 6.33%	16,200 $3.2 Million
Q2 2024 Jul 10, 2024	BUY	$154.79 - $180.76 $18,420 - $21,510	119 Added 0.69%	17,294 $2.97 Million
Q1 2024 Apr 17, 2024	SELL	$159.82 - $182.1 $239,250 - $272,603	-1,497 Reduced 8.02%	17,175 $3.13 Million
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $18,163 - $20,456	132 Added 0.71%	18,672 $2.89 Million
Q3 2023 Oct 20, 2023	BUY	$133.59 - $154.65 $15,897 - $18,403	119 Added 0.65%	18,540 $2.76 Million
Q2 2023 Jul 21, 2023	BUY	$132.51 - $164.9 $16,166 - $20,117	122 Added 0.67%	18,421 $2.48 Million
Q1 2023 Apr 11, 2023	BUY	$144.61 - $166.54 $37,743 - $43,466	261 Added 1.45%	18,299 $2.92 Million
Q4 2022 Jan 23, 2023	BUY	$138.31 - $165.87 $16,873 - $20,236	122 Added 0.68%	18,038 $0
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $82,673 - $94,820	-616 Reduced 3.32%	17,916 $2.4 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $300,424 - $381,937	-2,183 Reduced 10.54%	18,532 $2.84 Million
Q1 2022 May 10, 2022	BUY	$131.98 - $163.75 $791 - $982	6 Added 0.03%	20,715 $3.36 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $245,477 - $310,600	-2,285 Reduced 9.94%	20,709 $2.8 Million
Q3 2021 Oct 29, 2021	BUY	$106.4 - $120.78 $19,045 - $21,619	179 Added 0.78%	22,994 $2.48 Million
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $315 - $351	-3 Reduced 0.01%	22,815 $2.57 Million
Q1 2021 May 03, 2021	BUY	$102.3 - $112.62 $15,447 - $17,005	151 Added 0.67%	22,818 $2.47 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $42,015 - $56,725	522 Added 2.36%	22,667 $2.39 Million
Q3 2020 Oct 13, 2020	SELL	$85.91 - $100.83 $69,587 - $81,672	-810 Reduced 3.53%	22,145 $1.94 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $31,255 - $41,824	-426 Reduced 1.82%	22,955 $2.25 Million
Q1 2020 May 01, 2020	BUY	$64.5 - $97.79 $25,671 - $38,920	398 Added 1.73%	23,381 $1.78 Million
Q4 2019 Feb 07, 2020	BUY	$72.13 - $90.25 $1,803 - $2,256	25 Added 0.11%	22,983 $2.03 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $16,941 - $20,368	269 Added 1.19%	22,958 $1.74 Million
Q2 2019 Jul 31, 2019	BUY	$65.7 - $83.98 $3,876 - $4,954	59 Added 0.26%	22,689 $1.65 Million
Q1 2019 Apr 25, 2019	BUY	$77.14 - $90.79 $16,585 - $19,519	215 Added 0.96%	22,630 $1.82 Million
Q4 2018 Jan 10, 2019	BUY	$77.85 - $96.01 $3,425 - $4,224	44 Added 0.2%	22,415 $2.07 Million
Q3 2018 Nov 08, 2018	BUY	$88.91 - $98.84 $35,030 - $38,942	394 Added 1.79%	22,371 $2.12 Million
Q2 2018 Aug 02, 2018	BUY	$89.78 - $106.23 $28,909 - $34,206	322 Added 1.49%	21,977 $2.04 Million
Q1 2018 Apr 20, 2018	SELL	$92.01 - $123.21 $79,588 - $106,576	-865 Reduced 3.84%	21,655 $2.05 Million
Q4 2017 Jan 24, 2018	SELL	$89.56 - $98.21 $10,209 - $11,195	-114 Reduced 0.5%	22,520 $2.18 Million
Q3 2017 Oct 24, 2017	BUY	$69.85 - $89.22 $11,176 - $14,275	160 Added 0.71%	22,634 $2.01 Million
Q2 2017 Sep 18, 2017	BUY	N/A	22,474	22,474 $1.58 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mps Loria Financial Planners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mps Loria Financial Planners, LLC with notifications on news.

Account

Mps Loria Financial Planners, LLC Abb Vie Inc. Transaction History